beauvericin has been researched along with Fungal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammar, R; Andes, D; Averette, AF; Bahn, YS; Coccetti, P; Cowen, LE; Döhl, K; Gingras, AC; Gunaherath, GM; Gunatilaka, AA; Heitman, J; Kim, T; Lambert, JP; Lee, SC; Loewith, RJ; Niewola-Staszkowska, K; Nislow, C; Roth, FP; Sanglard, D; Schmitt, L; Shekhar-Guturja, T; Tripodi, F; Wijeratne, EM | 1 |
| An, R; Bian, J; Chen, X; Chen, Z; Dai, H; Fu, C; Gao, H; Goodfellow, M; Huang, R; Jiang, Y; Kuai, J; Liu, J; Liu, Z; Min, F; Pei, G; Song, Y; Sun, H; Sun, N; Wang, J; Yan, K; Yang, K; You, J; Yu, Z; Zhang, L; Zhang, S; Zhang, X; Zhang, Y; Zhao, W; Zheng, C; Zhou, G; Zhuo, Y | 1 |
2 other study(ies) available for beauvericin and Fungal Diseases
| Article | Year |
|---|---|
Dual action antifungal small molecule modulates multidrug efflux and TOR signaling.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Depsipeptides; Drug Resistance, Fungal; Drug Resistance, Multiple; Fungi; HSP90 Heat-Shock Proteins; Microbial Sensitivity Tests; Mycoses; Protein Kinase Inhibitors; Saccharomyces cerevisiae Proteins; Signal Transduction; Small Molecule Libraries; TOR Serine-Threonine Kinases | 2016 |
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections.
Topics: Algorithms; Animals; Antifungal Agents; Cell Line; Depsipeptides; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Humans; Immunocompromised Host; Ketoconazole; Mice; Microbial Sensitivity Tests; Mycoses | 2007 |